title: Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
abstract: We compared initial screening data of 44,082 white and 27,124 black Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Each underwent serum transferrin saturation (TfSat) and ferritin (SF) measurements without regard to fasting, and HFE C282Y and H63D genotyping. Elevated measurements were defined as: TfSat more than 50% (men), more than 45% (women); and SF more than 300 ng/ml (men), more than 200 ng/ml (women). Mean TfSat and percentages of participants with elevated TfSat were significantly greater in whites than in blacks. Mean SF and percentages of participants with elevated SF were significantly greater in blacks than in whites. TfSat and SF varied by gender and age in whites and blacks. Prevalences of genotypes that included either C282Y or H63D were significantly greater in whites than in blacks. The prevalence of elevated TfSat and SF plus genotypes C282Y/C282Y, C282Y/H63D, or H63D/H63D was 0.006 in whites and 0.0003 in blacks. Among whites with HFE C282Y homozygosity, 76.8% of men and 46.9% of women had elevated TfSat and SF values. Three black participants had HFE C282Y homozygosity; one had elevated TfSat and SF values. Possible explanations for differences in TfSat and SF in whites and blacks and pertinence to the detection of hemochromatosis, iron overload, and other disorders with similar phenotypes are discussed.
authors.affiliation: Southern Iron Disorders Center, Birmingham, Alabama 35209, USA. ironmd@dnamail.com
authors.forename: James C
authors.initials: JC
authors.lastname: Barton
authors.forename: Ronald T
authors.initials: RT
authors.lastname: Acton
authors.forename: Fitzroy W
authors.initials: FW
authors.lastname: Dawkins
authors.forename: Paul C
authors.initials: PC
authors.lastname: Adams
authors.forename: Laura
authors.initials: L
authors.lastname: Lovato
authors.forename: Cathie
authors.initials: C
authors.lastname: Leiendecker-Foster
authors.forename: Christine E
authors.initials: CE
authors.lastname: McLaren
authors.forename: David M
authors.initials: DM
authors.lastname: Reboussin
authors.forename: Mark R
authors.initials: MR
authors.lastname: Speechley
authors.forename: Victor R
authors.initials: VR
authors.lastname: Gordeuk
authors.forename: Gordon D
authors.initials: GD
authors.lastname: McLaren
authors.forename: Phyliss
authors.initials: P
authors.lastname: Sholinsky
authors.forename: Emily L
authors.initials: EL
authors.lastname: Harris
mesh_terms: D000328:Adult; D044383:Black People / Q000235:genetics*; D005260:Female; D005293:Ferritins / Q000097:blood*; D005838:Genotype; D006432:Hemochromatosis / Q000175:diagnosis / Q000235:genetics*; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006801:Humans; D008297:Male; D008403:Mass Screening; D008565:Membrane Proteins / Q000235:genetics*; D010641:Phenotype; D014168:Transferrin / Q000378:metabolism*; D044465:White People / Q000235:genetics*
chemical_list: C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins; D014168:Transferrin; D005293:Ferritins